Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CATX
DateTimeSourceHeadlineSymbolCompany
21/02/202523:00GlobeNewswire Inc.Perspective Therapeutics to Provide Business Highlights and Report Full Year 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
15/02/202503:37Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
15/02/202502:26Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
05/02/202523:00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming February Investor ConferencesAMEX:CATXPerspective Therapeutics Inc
04/02/202508:09Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
24/01/202523:26Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
24/01/202523:00GlobeNewswire Inc.Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers SymposiumAMEX:CATXPerspective Therapeutics Inc
22/01/202523:00GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025AMEX:CATXPerspective Therapeutics Inc
14/01/202500:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
14/01/202500:00GlobeNewswire Inc.Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
10/01/202523:00GlobeNewswire Inc.Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
08/01/202508:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
08/01/202508:48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
07/01/202500:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
07/01/202500:00GlobeNewswire Inc.Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial OfficerAMEX:CATXPerspective Therapeutics Inc
07/12/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
05/12/202409:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
05/12/202409:17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
05/12/202409:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
27/11/202423:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
27/11/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
27/11/202423:00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in DecemberAMEX:CATXPerspective Therapeutics Inc
26/11/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
21/11/202423:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
21/11/202423:15GlobeNewswire Inc.Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical SymposiumAMEX:CATXPerspective Therapeutics Inc
16/11/202408:08GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024AMEX:CATXPerspective Therapeutics Inc
15/11/202423:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
15/11/202410:14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
15/11/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
15/11/202402:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:CATX